More normal business drives the performance
30/10/24 -"Nivea and Eucerin posted robust growth in the Q3, driven by innovation and strong demand in emerging markets. This is expected to result in increased profitability in the H2, although it will be ..."
Pages
56
Language
English
Published on
30/10/24
You may also be interested by these reports :
10/11/25
The Q3 2025 results came largely as expected, with Adhesive Technologies performing in line, driven by its futuristic solutions. Consumer Brands ...
03/11/25
Puig delivered an impressive Q3 25, beating expectations with extraordinary momentum in makeup and solid progress in Asia. The group raised its FY25 ...
30/10/25
Haleon’s Q3 sales aligned with expectations, driven by growth in Oral Health, VMS, Pain Relief, and Digestive Health. This was partially offset by ...
30/10/25
Essity delivered a profit beat for Q3 2025, with an Adj. EBITA of SEK 5,056m and an impressive 14.6% margin, exceeding consensus despite in-line net ...